Anhui Fengyuan Pharmaceutical Co., Ltd. (SHE:000153)
China · Delayed Price · Currency is CNY 5.41
-0.08 (-1.46%)
Jun 11, 2026, 3:04 PM CST
SHE:000153 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 94.8 | 160.83 | 159.29 | 154.43 | 122.98 |
Depreciation & Amortization | 148.37 | 127.43 | 126.32 | 121.7 | 115.31 |
Other Amortization | 14.59 | 16.5 | 14.44 | 13.02 | 10.94 |
Loss (Gain) From Sale of Assets | 0.33 | 1.61 | -4.38 | 0.25 | 0.51 |
Asset Writedown & Restructuring Costs | 17.54 | 0.01 | 0.28 | 0.01 | 8.57 |
Loss (Gain) From Sale of Investments | -8.56 | -3.94 | 1.58 | -14.82 | -9.73 |
Provision & Write-off of Bad Debts | - | 7.38 | 0.69 | 4.51 | 1.54 |
Other Operating Activities | 53.6 | 34.64 | 36.91 | 39.35 | 40.39 |
Change in Accounts Receivable | -52.62 | -165.39 | -238.77 | -89.26 | -114.07 |
Change in Inventory | 46.05 | -18.38 | 126.41 | -44.9 | -40.4 |
Change in Accounts Payable | -188.35 | -33.2 | 54.5 | 261.41 | 138.84 |
Operating Cash Flow | 119.3 | 126.24 | 254.75 | 439.99 | 264.62 |
Operating Cash Flow Growth | -5.50% | -50.45% | -42.10% | 66.27% | -9.61% |
Capital Expenditures | -220.61 | -144.02 | -152.12 | -81.76 | -159.84 |
Sale of Property, Plant & Equipment | 0.41 | 0.47 | 3.1 | 5.63 | 1.05 |
Investment in Securities | -58.6 | -117.18 | - | -27 | 6.9 |
Other Investing Activities | 8.56 | 9.27 | 5.36 | 3.74 | 0.34 |
Investing Cash Flow | -270.24 | -251.45 | -143.66 | -99.39 | -151.56 |
Long-Term Debt Issued | 1,534 | 1,156 | 887.62 | 855.6 | 900.6 |
Total Debt Issued | 1,534 | 1,156 | 887.62 | 855.6 | 900.6 |
Long-Term Debt Repaid | -1,234 | -1,033 | -993.2 | -834.56 | -1,002 |
Total Debt Repaid | -1,234 | -1,033 | -993.2 | -834.56 | -1,002 |
Net Debt Issued (Repaid) | 299.89 | 123.08 | -105.58 | 21.04 | -100.99 |
Issuance of Common Stock | - | - | - | 82.48 | - |
Repurchase of Common Stock | - | -0.18 | -0.35 | - | - |
Common Dividends Paid | -81.16 | -72.17 | -64.17 | -57.48 | -26.28 |
Other Financing Activities | -155.6 | -0.1 | 4.9 | -308.31 | - |
Financing Cash Flow | 63.12 | 50.63 | -165.2 | -262.27 | -127.27 |
Foreign Exchange Rate Adjustments | -0.02 | 0.17 | 0.17 | 0.09 | -0.34 |
Net Cash Flow | -87.84 | -74.43 | -53.93 | 78.42 | -14.54 |
Free Cash Flow | -101.31 | -17.78 | 102.64 | 358.23 | 104.78 |
Free Cash Flow Growth | - | - | -71.35% | 241.90% | 2.71% |
Free Cash Flow Margin | -2.63% | -0.41% | 2.40% | 8.95% | 2.87% |
Free Cash Flow Per Share | -0.22 | -0.04 | 0.22 | 0.81 | 0.24 |
Cash Income Tax Paid | 176.72 | 206.74 | 282.07 | 180.28 | 181.46 |
Levered Free Cash Flow | 236.02 | -132.77 | -126.98 | 450.22 | -145.6 |
Unlevered Free Cash Flow | 236.02 | -113.79 | -105.8 | 470.76 | -121.06 |
Change in Working Capital | -201.38 | -218.23 | -80.37 | 121.54 | -25.9 |